Cantel Medical Corp. (CMD) Announces Semi-Annual Dividend of $0.09
Cantel Medical Corp. (NYSE:CMD) announced a Semi-Annual dividend on Wednesday, November 1st, Zacks reports. Investors of record on Wednesday, January 17th will be paid a dividend of 0.085 per share on Wednesday, January 31st. The ex-dividend date is Tuesday, January 16th.
Cantel Medical Corp. has a payout ratio of 6.0% indicating that its dividend is sufficiently covered by earnings. Equities analysts expect Cantel Medical Corp. to earn $2.65 per share next year, which means the company should continue to be able to cover its $0.14 annual dividend with an expected future payout ratio of 5.3%.
Cantel Medical Corp. (NYSE:CMD) last released its quarterly earnings results on Thursday, September 28th. The company reported $0.54 earnings per share for the quarter, beating analysts’ consensus estimates of $0.52 by $0.02. The business had revenue of $205.50 million for the quarter, compared to the consensus estimate of $200.32 million. Cantel Medical Corp. had a net margin of 9.27% and a return on equity of 17.60%. The business’s quarterly revenue was up 14.8% compared to the same quarter last year.
In related news, Chairman Charles M. Diker sold 20,500 shares of the firm’s stock in a transaction on Wednesday, October 4th. The shares were sold at an average price of $99.15, for a total value of $2,032,575.00. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Eric W. Nodiff sold 2,868 shares of the firm’s stock in a transaction on Friday, October 20th. The shares were sold at an average price of $97.55, for a total transaction of $279,773.40. Following the completion of the transaction, the executive vice president now owns 39,102 shares in the company, valued at $3,814,400.10. The disclosure for this sale can be found here. Insiders sold a total of 36,368 shares of company stock worth $3,576,028 over the last quarter. 14.90% of the stock is currently owned by company insiders.
CMD has been the topic of a number of recent research reports. Sidoti upgraded shares of Cantel Medical Corp. from a “neutral” rating to a “buy” rating and set a $92.00 price target on the stock in a report on Wednesday, August 2nd. Zacks Investment Research upgraded shares of Cantel Medical Corp. from a “hold” rating to a “buy” rating and set a $83.00 price target on the stock in a report on Tuesday, August 1st. Finally, Needham & Company LLC restated a “hold” rating on shares of Cantel Medical Corp. in a report on Friday, September 1st. Four analysts have rated the stock with a hold rating and one has given a buy rating to the company’s stock. Cantel Medical Corp. presently has a consensus rating of “Hold” and a consensus target price of $91.67.
TRADEMARK VIOLATION WARNING: “Cantel Medical Corp. (CMD) Announces Semi-Annual Dividend of $0.09” was first posted by American Banking News and is owned by of American Banking News. If you are accessing this piece on another website, it was illegally stolen and reposted in violation of US and international copyright & trademark laws. The legal version of this piece can be accessed at https://www.americanbankingnews.com/2017/11/02/cantel-medical-corp-cmd-announces-semi-annual-dividend-of-0-09.html.
About Cantel Medical Corp.
Cantel Medical Corp. is a provider of infection prevention products and services in the healthcare market. The Company’s operating segments include Endoscopy; Water Purification and Filtration; Healthcare Disposables, and Dialysis. Its Endoscopy segment includes medical device reprocessing systems, disinfectants, detergents and other supplies.
Receive News & Ratings for Cantel Medical Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cantel Medical Corp. and related companies with MarketBeat.com's FREE daily email newsletter.